Radiotherapy Market

Table of Contents

1 Introduction (Page No. - 21)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Stakeholders

2 Research Methodology (Page No. - 24)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
    2.2 Market Size Estimation
           2.2.1 Product-Based Market Estimation
           2.2.2 Primary Research Validation
    2.3 Market Breakdown and Data Triangulation
    2.4 Research Limitations and Assumptions
           2.4.1 Limitations
           2.4.2 Assumptions

3 Executive Summary (Page No. - 35)

4 Premium Insights (Page No. - 40)
    4.1 Market Overview
    4.2 Europe: External Market, By Type, 2018
    4.3 Internal Beam Radiotherapy/Brachytherapy Market, By Product Type
    4.4 External Beam Market, By Application
    4.5 Regional Analysis: Market, By End User
    4.6 Market, By Country

5 Market Overview (Page No. - 46)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Technological Advancements
                    5.2.1.2 Rising Prevalence of Cancer
                    5.2.1.3 Increasing Number of Conferences and Symposia Focusing on Spreading Awareness About the Benefits of Radiotherapy
                    5.2.1.4 Growing Use of Particle Therapy for Cancer Treatment
           5.2.2 Restraints
                    5.2.2.1 Lack of Adequate Healthcare Infrastructure
                    5.2.2.2 Shortage of Trained Personnel
                    5.2.2.3 Affordability and Accessibility of Treatment
                    5.2.2.4 Complex Nature of Radiotherapy
           5.2.3 Opportunities
                    5.2.3.1 Emerging Markets
                    5.2.3.2 Growing Government and Private Investments to Meet the Increasing Demand for Cancer Treatment
                    5.2.3.3 Improving Reimbursement Scenario
           5.2.4 Challenges
                    5.2.4.1 Difficulties in Visualizing Tumors During Radiotherapy Procedures
                    5.2.4.2 Risk of Radiation Exposure
    5.3 Industry Trends
           5.3.1 Growing Adoption of Pencil-Beam Scanning
           5.3.2 Growing Number of Collaborations and Acquisitions

6 Radiotherapy Market, By Product Type (Page No. - 58)
    6.1 Introduction
    6.2 External Beam Radiotherapy
           6.2.1 Linear Accelerators
                    6.2.1.1 Conventional Linear Accelerators
                               6.2.1.1.1 Lower Equipment and Maintenance Cost Will Drive the Market for Conventional Linacs
                    6.2.1.2 Stereotactic Advanced Electron/Cobalt-60 Linear Accelerators
                               6.2.1.2.1 Automation and Real-Time Tracking Features Have Ensured Demand for Stereotactic Advanced Linac
                               6.2.1.2.2 Gamma Knife
                                             6.2.1.2.2.1 The Gamma Knife System is Considered A Gold Standard for Brain Tumor Treatment
                               6.2.1.2.3 Cyberknife
                                             6.2.1.2.3.1 Cyberknife Offers A Precise Radiation Delivery Method With Specialized Tracking and Robotic Correction Capabilities
                               6.2.1.2.4 Tomotherapy
                                             6.2.1.2.4.1 360-Degree (Helical) Radiation Treatment With Tomotherapy is Adding Growth Opportunities to This Segment
           6.2.2 Particle Therapy Systems
                    6.2.2.1 Cyclotrons
                               6.2.2.1.1 Leading Players in the Particle Therapy Market Mainly Manufacture Cyclotrons
                    6.2.2.2 Synchrotrons
                               6.2.2.2.1 Increasing Investment for the Development of Synchrotron Facilities are Contributing to Market Growth
                    6.2.2.3 Synchrocyclotrons
                               6.2.2.3.1 High Space Requirements of Synchrocyclotrons are Limiting Its Widespread Adoption
           6.2.3 Conventional Cobalt-60 Teletherapy Units
                    6.2.3.1 High Cost and Risk of Radiation Exposure With Cobalt-60 Radioisotopes Have Hindered the Growth of This Segment
    6.3 Internal Beam Radiotherapy/Brachytherapy
           6.3.1 Seeds
                    6.3.1.1 Adverse Side-Effects Associated With Seeds Limit Their Adoption
           6.3.2 Applicators
                    6.3.2.1 Manual Applicators Pose A High Risk of Radiation Exposure to the Patients and Staff
           6.3.3 Afterloaders
                    6.3.3.1 Modern Afterloaders Offer Proper Positioning and Better Control of Isotopes Inside the Patient Body
           6.3.4 Electronic Brachytherapy Products
                    6.3.4.1 Electronic Brachytherapy Requires Low Amount of Shielding Than Alternatives
    6.4 Systemic Radiotherapy
           6.4.1 Iobenguane (I-131)
                    6.4.1.1 Increasing Incidence of Thyroid Cancer is Driving the Growth of This Segment
           6.4.2 Samarium-153
                    6.4.2.1 Samarium-153 has Wide Applications for Bone Metastasis
           6.4.3 Rhenium-186
                    6.4.3.1 Lack of Insurance Coverage With the Use of Rhenium-186 Restricting Its Growth
           6.4.4 Other Systemic Radiotherapy Products

7 Radiotherapy Market, By Type (Page No. - 80)
    7.1 Introduction
    7.2 External Beam Radiotherapy
           7.2.1 Image-Guided Radiotherapy
                    7.2.1.1 Image-Guided Radiotherapy is Widely Used to the Treatment of Deep-Seated Tumors
           7.2.2 3d Conformal Radiotherapy
                    7.2.2.1 Multiple Beams With 3d-Crt Allow Precise Radiation Conforming to the Tumor Size and Shape
           7.2.3 Intensity-Modulated Radiotherapy
                    7.2.3.1 Volumetric Arc Therapy
                               7.2.3.1.1 Advancements in the Vmat Technology Driving Its Widespread Adoption
                    7.2.3.2 Tomotherapy
                               7.2.3.2.1 Minimal Exposure to Normal Tissues – A Major Advantage of Tomotherapy
           7.2.4 Stereotactic Therapy
                    7.2.4.1 Stereotactic Therapy Offers A Minimally Invasive Alternative to Ablation Surgeries
           7.2.5 Particle Therapy
                    7.2.5.1 Particle Therapy is Increasingly Being Adopted as A Primary Mode of Treatment for Various Cancer Types
    7.3 Internal Beam Radiotherapy
           7.3.1 Low-Dose-Rate Brachytherapy
                    7.3.1.1 Lower Risk of Radiation Exposure to the Surrounding Tissues With Ldr Supporting Market Growth
           7.3.2 High-Dose-Rate Brachytherapy
                    7.3.2.1 Better Patient Care With HDR is Driving Its Widespread Adoption
           7.3.3 Pulsed-Dose-Rate Brachytherapy
                    7.3.3.1 Pulsed-Dose Rate Brachytherapy Combines the Advantages of HDR and Ldr Brachytherapy
    7.4 Systemic Radiotherapy
           7.4.1 Intravenous Radiotherapy
                    7.4.1.1 Intravenous Route of Brachytherapy Results in Maximum Bioavailability
           7.4.2 Oral Radiotherapy
                    7.4.2.1 Longer Distribution Time Associated With the Oral Mode of Radiation Delivery Limiting Its Demand
           7.4.3 Instillation Radiotherapy
                    7.4.3.1 Lesser Localization With Instillation Brachytherapy is Limiting Its Widespread Adoption

8 Radiotherapy Market, By Application (Page No. - 97)
    8.1 Introduction
    8.2 External Beam Radiation Therapy
           8.2.1 Prostate Cancer
                    8.2.1.1 High Incidence of Prostate Cancer Will Drive the Demand for Ebrt
           8.2.2 Breast Cancer
                    8.2.2.1 Adoption of Advanced Ebrt Systems and Increasing Research Will Drive Market Growth
           8.2.3 Lung Cancer
                    8.2.3.1 Radiotherapy Can Be Used as Solo Or Combination Therapy for Lung Cancer
           8.2.4 Head and Neck Cancer
                    8.2.4.1 Benefits of External Radiotherapy Will Support Its Use in Head and Neck Cancer Treatment
           8.2.5 Colorectal Cancer
                    8.2.5.1 Availability of Alternative Therapeutic Options Limits the Growth of This Segment
           8.2.6 Other Cancers
    8.3 Internal Beam Radiotherapy/Brachytherapy
           8.3.1 Prostate Cancer
                    8.3.1.1 Rapidity and Precision of Brachytherapy in Prostate Cancer Treatment Have Driven Market Growth
           8.3.2 Gynecological Cancer
                    8.3.2.1 Availability of Alternatives Hinders the Adoption of Brachytherapy in Gynecological Cancer Treatment
           8.3.3 Breast Cancer
                    8.3.3.1 Precision and Rapid Treatment Times are Driving the Use of Brachytherapy in Breast Cancer Applications
           8.3.4 Cervical Cancer
                    8.3.4.1 A Combination of Brachytherapy and Chemotherapy is Typically Used for Cervical Cancer Treatment
           8.3.5 Penile Cancer
                    8.3.5.1 Advantages of Brachytherapy in Penile Cancer Treatment Have Driven Its Adoption
           8.3.6 Other Cancers

9 Radiotherapy Market, By End User (Page No. - 114)
    9.1 Introduction
           9.1.1 Hospitals
                    9.1.1.1 Increasing Number of Small-Footprint Advanced Radiotherapy Products Promoting Their Adoption in Hospitals
           9.1.2 Independent Radiotherapy Centers
                    9.1.2.1 Rising Consolidation of Healthcare Networks is Challenging the Growth of Freestanding Radiotherapy Centers

10 Radiotherapy Market, By Region (Page No. - 119)
     10.1 Introduction
     10.2 North America
             10.2.1 US
                        10.2.1.1 Growing Government Initiatives Boosting the Adoption of Radiotherapy in the Us
             10.2.2 Canada
                        10.2.2.1 Rising Cancer Incidence Driving the Demand for Radiotherapy in Canada
     10.3 Europe
             10.3.1 Germany
                        10.3.1.1 Increasing Awareness of Novel and Advanced Radiotherapy Products A Key Factor Contributing to Market Growth
             10.3.2 France
                        10.3.2.1 Growing Government Initiatives Boosting the Adoption of Radiotherapy in France
             10.3.3 UK
                        10.3.3.1 Leading Market Players Focusing on Expanding Their Product Offerings in the Uk
             10.3.4 Rest of Europe
     10.4 Asia Pacific
             10.4.1 China
                        10.4.1.1 Presence of A Large Number of Local Manufactures Supporting the Growth of the Radiotherapy Market in China
             10.4.2 Japan
                        10.4.2.1 Rising Prevalence of Cancer is Driving the Adoption of Radiotherapy in Japan
             10.4.3 India
                        10.4.3.1 Shortage of Skilled Radiotherapy Professionals in India is Restraining Market Growth
             10.4.4 Rest of Asia Pacific
     10.5 Rest of the World

11 Competitive Landscape (Page No. - 173)
     11.1 Introduction
     11.2 Market Share Analysis
     11.3 Competitive Scenario
             11.3.1 Product Launches and Approvals
             11.3.2 Acquisitions
             11.3.3 Expansions
             11.3.4 Partnerships, Agreements, and Collaborations
     11.4 Vendor Dive Overview
     11.5 Vendor Inclusion Criteria
     11.6 Vendor Dive
             11.6.1 Vanguards
             11.6.2 Innovators
             11.6.3 Dynamic Players
             11.6.4 Emerging Companies

12 Company Profiles (Page No. - 182)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
     12.1 Accuray Incorporated
     12.2 C. R. Bard, Inc.
     12.3 Elekta
     12.4 Hitachi, Ltd.
     12.5 IBA (Ion Beam Applications Sa)
     12.6 Isoray Medical, Inc.
     12.7 Mevion Medical Systems, Inc.
     12.8 Optivus Proton Therapy, Inc.
     12.9 Panacea Medical Technologies Pvt. Ltd.
     12.10 P-Cure Ltd.
     12.11 Provision Healthcare, LLC.
     12.12 Sumitomo Heavy Industries, Ltd
     12.13 Theragenics Corporation
     12.14 Varian Medical Systems, Inc.
     12.15 Viewray Inc.

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. - 218)
     13.1 Discussion Guide
     13.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
     13.3 Available Customizations
     13.4 Related Reports
     13.5 Author Details

List of Tables (150 Tables)

Table 1 National Average Medicare Reimbursement: Outpatient Prospective Payment System (Opps) Estimated Per Course
Table 2 Radiotherapy Market, By Product Type, 2016–2023 (USD Million)
Table 3 External Beam Market, By Product Type, 2016–2023 (USD Million)
Table 4 External Beam Market, By Region, 2016–2023 (USD Million)
Table 5 External Beam Market for Linear Accelerators, By Type, 2016–2023 (USD Million)
Table 6 External Beam Market for Linear Accelerators, By Region, 2016–2023 (USD Million)
Table 7 Conventional Linear Accelerators Market, By Region, 2016–2023 (USD Million)
Table 8 Stereotactic Advanced Electron/Cobalt-60 Linac Market, By Product Type, 2016–2023 (USD Million)
Table 9 Stereotactic Advanced Electron/Cobalt-60 Linear Accelerators Market, By Region, 2016–2023 (USD Million)
Table 10 Gamma Knife Market, By Region, 2016–2023 (USD Million)
Table 11 Cyberknife Market, By Region, 2016–2023 (USD Million)
Table 12 Tomotherapy Market, By Region, 2016–2023 (USD Million)
Table 13 External Beam Radiotherapy Market for Particle Therapy Systems, By Product Type, 2016–2023 (USD Million)
Table 14 External Beam Market for Particle Therapy Systems, By Region, 2016–2023 (USD Million)
Table 15 Particle Therapy Systems Market for Cyclotrons, By Region, 2016–2023 (USD Million)
Table 16 Particle Therapy Systems Market for Synchrotrons, By Region, 2016–2023 (USD Million)
Table 17 Particle Therapy Systems Market for Synchrocyclotrons, By Region, 2016–2023 (USD Million)
Table 18 External Beam Market for Conventional Cobalt-60 Teletherapy Units, By Region, 2016–2023 (USD Million)
Table 19 Internal Beam Radiotherapy/Brachytherapy Market, By Product Type, 2016–2023 (USD Million)
Table 20 Internal Beam Radiotherapy/Brachytherapy Market, By Region, 2016–2023 (USD Million)
Table 21 Internal Beam Radiotherapy/Brachytherapy Market for Seeds, By Region, 2016–2023 (USD Million)
Table 22 Internal Beam Radiotherapy/Brachytherapy Market for Applicators, By Region, 2016–2023 (USD Million)
Table 23 Internal Beam Radiotherapy/Brachytherapy Market for Afterloaders, By Region, 2016–2023 (USD Million)
Table 24 Internal Beam Radiotherapy/Brachytherapy Market for Electronic Brachytherapy Products, By Region, 2016–2023 (USD Million)
Table 25 Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 26 External Beam Market, By Type, 2016–2023 (USD Million)
Table 27 External Beam Market, By Region, 2016–2023 (USD Million)
Table 28 Image-Guided Market, By Region, 2016–2023 (USD Million)
Table 29 3d Conformal Market, By Region, 2016–2023 (USD Million)
Table 30 Intensity-Modulated Market, By Type, 2016–2023 (USD Million)
Table 31 Intensity-Modulated Market, By Region, 2016–2023 (USD Million)
Table 32 Volumetric Arc Therapy Market, By Region, 2016–2023 (USD Million)
Table 33 Tomotherapy Market, By Region, 2016–2023 (USD Million)
Table 34 Stereotactic Therapy Market, By Region, 2016–2023 (USD Million)
Table 35 Particle Therapy Market, By Region, 2016–2023 (USD Million)
Table 36 Internal Beam Radiotherapy/Brachytherapy Market, By Type, 2016–2023 (USD Million)
Table 37 Internal Beam Radiotherapy/Brachytherapy Market, By Region, 2016–2023 (USD Million)
Table 38 Low-Dose-Rate Brachytherapy Market, By Region, 2016–2023 (USD Million)
Table 39 High-Dose-Rate Brachytherapy Market, By Region, 2016–2023 (USD Million)
Table 40 Pulsed-Dose-Rate Brachytherapy Market, By Region, 2016–2023 (USD Million)
Table 41 Radiotherapy Applications Market, By Type, 2016-2023 (USD Million)
Table 42 External Beam Radiotherapy Applications Market, By Type, 2016-2023 (USD Million)
Table 43 External Beam Radiotherapy Applications Market for Prostate Cancer, By Region, 2016-2023 (USD Million)
Table 44 External Beam Radiotherapy Applications Market for Breast Cancer, By Region, 2016-2023 (USD Million)
Table 45 External Beam Radiotherapy Applications Market for Lung Cancer, By Region, 2016-2023 (USD Million)
Table 46 External Beam Radiotherapy Applications Market for Head and Neck Cancer, By Region, 2016-2023 (USD Million)
Table 47 External Beam Radiotherapy Applications Market for Colorectal Cancer, By Region, 2016-2023 (USD Million)
Table 48 External Beam Radiotherapy Applications Market for Other Cancers, By Region, 2016-2023 (USD Million)
Table 49 Internal Beam Radiotherapy/Brachytherapy Applications Market, By Type, 2016-2023 (USD Million)
Table 50 Internal Beam Radiotherapy/Brachytherapy Applications Market for Prostate Cancer, By Region, 2016-2023 (USD Million)
Table 51 Internal Beam Radiotherapy/Brachytherapy Applications Market for Gynecological Cancer, By Region, 2016-2023 (USD Million)
Table 52 Internal Beam Radiotherapy/Brachytherapy Applications Market for Breast Cancer, By Region, 2016-2023 (USD Million)
Table 53 Internal Beam Radiotherapy/Brachytherapy Applications Market for Cervical Cancer, By Region, 2016-2023 (USD Million)
Table 54 Internal Beam Radiotherapy/Brachytherapy Applications Market for Penile Cancer, By Region, 2016-2023 (USD Million)
Table 55 Internal Beam Radiotherapy/Brachytherapy Applications Market for Other Cancers, By Region, 2016-2023 (USD Million)
Table 56 Radiotherapy Market, By End User, 2016–2023 (USD Million)
Table 57 Radiotherapy Market for Hospitals, By Region, 2016–2023 (USD Million)
Table 58 Radiotherapy Market for Independent Radiotherapy Centers, By Region, 2016–2023 (USD Million)
Table 59 Radiotherapy Market, By Region, 2016–2023 (USD Million)
Table 60 North America: Market, By Country, 2016–2023 (USD Million)
Table 61 North America: Market, By Type, 2016–2023 (USD Million)
Table 62 North America: External Beam Radiotherapy Market, By Product, 2016–2023 (USD Million)
Table 63 North America: Linear Accelerators Market, By Type, 2016–2023 (USD Million)
Table 64 North America: Stereotactic Advanced Linear Accelerators Market, By Type, 2016–2023 (USD Million)
Table 65 North America: Particle Therapy Systems Market, By Type, 2016–2023 (USD Million)
Table 66 North America: Internal Beam Radiotherapy/Brachytherapy Market, By Product, 2016–2023 (USD Million)
Table 67 North America: External Beam Market, By Type, 2016–2023 (USD Million)
Table 68 North America: Intensity-Modulated Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 69 North America: Internal Beam Radiotherapy/Brachytherapy Market, By Type, 2016–2023 (USD Million)
Table 70 North America: External Beam Radiotherapy Applications Market, By Type, 2016–2023 (USD Million)
Table 71 North America: Internal Beam Radiotherapy/Brachytherapy Applications Market, By Type, 2016–2023 (USD Million)
Table 72 North America: Radiotherapy Market, By End User, 2016–2023 (USD Million)
Table 73 US: Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 74 US: External Beam Market, By Product, 2016–2023 (USD Million)
Table 75 US: Linear Accelerators Market, By Type, 2016–2023 (USD Million)
Table 76 US: Internal Beam Radiotherapy/Brachytherapy Market, By Product, 2016–2023 (USD Million)
Table 77 Canada: Market, By Type, 2016–2023 (USD Million)
Table 78 Canada: External Beam Market, By Product, 2016–2023 (USD Million)
Table 79 Canada: Linear Accelerators Market, By Type, 2016–2023 (USD Million)
Table 80 Canada: Internal Beam Radiotherapy/Brachytherapy Market, By Product, 2016–2023 (USD Million)
Table 81 Europe: Radiotherapy Market, By Country, 2016–2023 (USD Million)
Table 82 Europe: Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 83 Europe: External Beam Market, By Product, 2016–2023 (USD Million)
Table 84 Europe: Linear Accelerators Market, By Type, 2016–2023 (USD Million)
Table 85 Europe: Stereotactic Advanced Linear Accelerators Market, By Type, 2016–2023 (USD Million)
Table 86 Europe: Particle Therapy Systems Market, By Type, 2016–2023 (USD Million)
Table 87 Europe: Internal Beam Radiotherapy/Brachytherapy Market, By Product, 2016–2023 (USD Million)
Table 88 Europe: External Beam Market, By Type, 2016–2023 (USD Million)
Table 89 Europe: External Beam Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 90 Europe: Internal Beam Radiotherapy/Brachytherapy Market, By Type, 2016–2023 (USD Million)
Table 91 Europe: External Beam Radiotherapy Applications Market, By Type, 2016–2023 (USD Million)
Table 92 Europe: Internal Beam Radiotherapy/Brachytherapy Applications Market, By Type, 2016–2023 (USD Million)
Table 93 Europe: Radiotherapy Market, By End User, 2016–2023 (USD Million)
Table 94 Germany: Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 95 Germany: External Beam Market, By Product, 2016–2023 (USD Million)
Table 96 Germany: Linear Accelerators Market, By Type, 2016–2023 (USD Million)
Table 97 Germany: Internal Beam Radiotherapy/Brachytherapy Market, By Product, 2016–2023 (USD Million)
Table 98 France: Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 99 France: External Beam Market, By Product, 2016–2023 (USD Million)
Table 100 France: Linear Accelerators Market, By Type, 2016–2023 (USD Million)
Table 101 France: Internal Beam Radiotherapy/Brachytherapy Market, By Product, 2016–2023 (USD Million)
Table 102 UK: Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 103 UK: External Beam Market, By Product, 2016–2023 (USD Million)
Table 104 UK: Linear Accelerators Market, By Type, 2016–2023 (USD Million)
Table 105 UK: Internal Beam Radiotherapy/Brachytherapy Market, By Product, 2016–2023 (USD Million)
Table 106 Rest of Europe: Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 107 Rest of Europe: External Beam Radiotherapy Market, By Product, 2016–2023 (USD Million)
Table 108 Rest of Europe: Linear Accelerators Market, By Type, 2016–2023 (USD Million)
Table 109 Rest of Europe: Internal Beam Radiotherapy/Brachytherapy Market, By Product, 2016–2023 (USD Million)
Table 110 Asia Pacific: Radiotherapy Market, By Country, 2016–2023 (USD Million)
Table 111 Asia Pacific: Market, By Type, 2016–2023 (USD Million)
Table 112 Asia Pacific: External Beam Market, By Product, 2016–2023 (USD Million)
Table 113 Asia Pacific: Linear Accelerators Market, By Type, 2016–2023 (USD Million)
Table 114 Asia Pacific: Stereotactic Advanced Linear Accelerators Market, By Product, 2016–2023 (USD Million)
Table 115 Asia Pacific: Particle Therapy Systems Market, By Product, 2016–2023 (USD Million)
Table 116 Asia Pacific: Internal Beam Radiotherapy/Brachytherapy Market, By Product, 2016–2023 (USD Million)
Table 117 Asia Pacific: External Beam Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 118 APAC: Intensity-Modulated Market, By Type, 2016–2023 (USD Million)
Table 119 Asia Pacific: Internal Beam Radiotherapy/Brachytherapy Market, By Type, 2016–2023 (USD Million)
Table 120 Asia Pacific: External Beam Radiotherapy Applications Market, By Type, 2016–2023 (USD Million)
Table 121 Asia Pacific: Internal Beam Radiotherapy/Brachytherapy Applications Market, By Type, 2016–2023 (USD Million)
Table 122 Asia Pacific: Radiotherapy Market, By End User, 2016–2023 (USD Million)
Table 123 China: Market, By Type, 2016–2023 (USD Million)
Table 124 China: External Beam Radiotherapy Market, By Product, 2016–2023 (USD Million)
Table 125 China: Linear Accelerators Market, By Type, 2016–2023 (USD Million)
Table 126 China: Internal Beam Radiotherapy/Brachytherapy Market, By Product, 2016–2023 (USD Million)
Table 127 Japan: Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 128 Japan: External Beam Market, By Product, 2016–2023 (USD Million)
Table 129 Japan: Linear Accelerators Market, By Type, 2016–2023 (USD Million)
Table 130 Japan: Internal Beam Radiotherapy/Brachytherapy Market, By Product, 2016–2023 (USD Million)
Table 131 India: Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 132 India: External Beam Market, By Product, 2016–2023 (USD Million)
Table 133 India: Linear Accelerators Market, By Type, 2016–2023 (USD Million)
Table 134 India: Internal Beam Radiotherapy/Brachytherapy Market, By Product, 2016–2023 (USD Million)
Table 135 RoAPAC: Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 136 RoAPAC: External Beam Radiotherapy Market, By Product, 2016–2023 (USD Million)
Table 137 RoAPAC: Linear Accelerators Market, By Type, 2016–2023 (USD Million)
Table 138 RoAPAC: Internal Beam Radiotherapy/Brachytherapy Market, By Product, 2016–2023 (USD Million)
Table 139 RoW: Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 140 RoW: External Beam Market, By Product, 2016–2023 (USD Million)
Table 141 RoW: Linear Accelerators Market, By Type, 2016–2023 (USD Million)
Table 142 RoW: Stereotactic Advanced Linear Accelerators Market, By Product, 2016–2023 (USD Million)
Table 143 RoW: Particle Therapy Systems Market, By Product, 2016–2023 (USD Million)
Table 144 RoW: Internal Beam Radiotherapy/Brachytherapy Market, By Product, 2016–2023 (USD Million)
Table 145 RoW: External Beam Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 146 RoW: Intensity-Modulated Market, By Type, 2016–2023 (USD Million)
Table 147 RoW: Internal Beam Radiotherapy/Brachytherapy Market, By Type, 2016–2023 (USD Million)
Table 148 RoW: External Beam Radiotherapy Applications Market, By Type, 2016–2023 (USD Million)
Table 149 RoW: Internal Beam Radiotherapy/Brachytherapy Applications Market, By Type, 2016–2023 (USD Million)
Table 150 RoW: Market, By End User, 2016–2023 (USD Million)

List of Figures (46 Figures)

Figure 1 Radiotherapy Market: Research Methodology Steps
Figure 2 Research Design
Figure 3 Breakdown of Primaries: Global Market
Figure 4 Research Methodology: Hypothesis Building
Figure 5 Radiotherapy Market Size Estimation: Bottom-Up Approach
Figure 6 Market Size Estimation: Top-Down Approach
Figure 7 Data Triangulation Methodology
Figure 8 Radiotherapy Market, By Type, 2018 (USD Million)
Figure 9 External Beam Market, By Product Type, 2018 vs 2023 (USD Million)
Figure 10 Internal Beam Market, By Product Type, 2018 vs 2023 (USD Million)
Figure 11 External Beam Radiotherapy Market Share, By Application, 2018 vs 2023
Figure 12 Radiotherapy Market , By End User, 2018 vs 2023 (USD Million)
Figure 13 Radiotherapy Market: Geographical Snapshot
Figure 14 Rising Cancer Prevalence Across the Globe is Driving Growth in the Radiotherapy Market
Figure 15 Image-Guided Radiotherapy to Dominate the External Beam Radiotherapy Market in Europe in 2018
Figure 16 Afterloaders to Register the Highest CAGR in the Market During the Forecast Period
Figure 17 Others Cancer Application Segment to Grow at the Fastest Rate in the External Beam Market During the Forecast Period
Figure 18 North America to Dominate the Radiotherapy End User Market in 2018
Figure 19 China to Register the Highest CAGR During the Forecast Period (2018–2023)
Figure 20 Radiotherapy Market: Drivers, Restraints, Opportunities, and Challenges
Figure 21 Incidence of Cancer, By Region, 2012–2020 (Thousand)
Figure 22 Particle Therapy Systems to Register Highest Growth in the External Beam Radiotherapy Market During the Forecast Period
Figure 23 Seeds to Dominate Internal Beam Radiotherapy Market During the Forecast Period
Figure 24 Image-Guided Radiotherapy Segment to Account for the Largest Share of the External Beam Market in 2018
Figure 25 Number of Particle Therapy Facilities Present (As of October 2018) & Under Construction Across the Globe
Figure 26 High-Dose-Rate Brachytherapy Segment is Expected to Account for the Largest Share of the Internal Beam Market in 2018
Figure 27 Prostate Cancer to Dominate the External Beam Radiotherapy Applications Market During the Forecast Period
Figure 28 Breast Cancer to Register Highest Growth in Internal Beam Radiotherapy/Brachytherapy Applications Market
Figure 29 Hospitals Segment to Grow at the Highest CAGR During the Forecast Period
Figure 30 North America: Radiotherapy Market Snapshot
Figure 31 Europe: Market Snapshot
Figure 32 Asia Pacific: Market Snapshot
Figure 33 RoW: Radiotherapy Market Snapshot
Figure 34 Key Developments in the Radiotherapy Market Between 2015–2018
Figure 35 Market Share, By Key Player, 2017
Figure 36 Competitive Leadership Mapping (Overall Market)
Figure 37 Competitive Leadership Mapping (SME/Start-Ups)
Figure 38 Accuray Incorporated: Company Snapshot (2018)
Figure 39 C. R. Bard, Inc.: Company Snapshot (2016)
Figure 40 Elekta Ab: Company Snapshot (2017)
Figure 41 Hitachi: Company Snapshot (2017)
Figure 42 Ion Beam Applications Sa: Company Snapshot (2017)
Figure 43 Isoray Medical, Inc.: Company Snapshot (2018)
Figure 44 Sumitomo Heavy Industries: Company Snapshot (2016)
Figure 45 Varian Medical Systems, Inc.: Company Snapshot (2018)
Figure 46 Viewray, Inc.: Company Snapshot (2017)

To get more details on this report,

The study involved four major activities to estimate the current market size for radiotherapy. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.

Secondary Research

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to in order to identify and collect information for this study.

Primary Research

The radiotherapy market comprises several stakeholders such as radiotherapy product manufacturers, suppliers and distributors, healthcare service providers, and research institutes. The demand side of this market is characterized by the increasing awareness about minimally invasive cancer treatment options and the global rise in the prevalence of cancer. The supply side is characterized by advancements in technology. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is the breakdown of primary respondents:

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the radiotherapy market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

• The key players in the industry and markets have been identified through extensive secondary research
• The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes
• All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Data Triangulation

After arriving at the overall market size using the market size estimation processes as explained above—the market was split into several segments and subsegments. In order to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the radiotherapy industry.

Report Objectives

• To define, describe, and forecast the global radiotherapy market on the basis of type, product type, application, end user, and region
• To provide detailed information regarding the major factors (drivers, restraints, opportunities, challenges, and trends) influencing the growth of the global radiotherapy market
• To strategically analyze the micromarkets with respect to individual growth trends, future prospects, and contributions to the global radiotherapy market
• To analyze the opportunities in the global radiotherapy market for key stakeholders and provide details of the competitive landscape for market leaders
• To forecast the size of the market segments with respect to four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (Latin America and the Middle East & Africa)
• To profile the key players in the global radiotherapy market and comprehensively analyze their market shares and core competencies
• To track and analyze competitive developments, such as product launches, agreements, partnerships, collaborations, and acquisitions in the global radiotherapy market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the present global radiotherapy market report:

Product Analysis

• Product matrix, which gives a detailed comparison of the product portfolios of the top five companies

Company Information

• Detailed analysis and profiling of additional market players (up to 5)